The federal judge who once steered the future of a bankrupt General Motors Co. is again in the driver’s seat, setting out rules for a fight over billions of dollars in claims tied to ignition switch defects.
Boehringer Ingelheim GmbH, the German family-owned drugmaker, agreed to pay $650 million to settle the majority of lawsuits filed over its blood thinner Pradaxa, which has been linked to more than 500 patient deaths.
General Motors Co.’s own engineers, along with newspaper auto writers, were talking about the ignition switch defect in several GM models almost a decade before the carmaker announced plans last month to recall 1.6 million vehicles.
Barely 26 years old, Zhang Xi has studied at an elite American university, worked for an investment bank in Hong Kong and an oil company in Beijing and now may launch an Internet startup with two friends.
The Georgia attorney whose wrongful death suit against General Motors Co. helped trigger the recall of 2.59 million cars is seeking to revive that case, alleging the automaker fraudulently withheld information ahead of a settlement.